Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Early responders (15% or more weight loss after 24 weeks) to the higher dose of Wegovy ® (semaglutide 7.2 mg) achieved on average 27.7% mean weight loss at week 72 in the STEP UP trial1 Participants
NVO Rallies 21% in a Month: How Should Investors Play the Stock?
12:25pm, Monday, 11'th May 2026
Novo Nordisk stock jumps 21% in a month after a Q1 beat and stronger GLP-1 demand, but pricing pressure and Eli Lilly rivalry still cloud its 2026 outlook.
Novo Nordisk GLP-1 pill launch impresses but price erosion keeps Citi on the sidelines
10:02am, Monday, 11'th May 2026
Shares in Novo Nordisk (NYSE:NVO) drew a cautious reception from Citi following first-quarter results that beat consensus expectations, with the bank...
Novo Nordisk GLP-1 pill launch impresses but price erosion keeps Citi on the sidelines
09:23am, Monday, 11'th May 2026
Shares in Novo Nordisk (NYSE:NVO) drew a cautious reception from Citi following first-quarter results that beat consensus expectations, with the bank raising its target price but retaining a neutral r
Zuckerberg backed-Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy
08:42am, Monday, 11'th May 2026
Meta CEO Mark Zuckerberg backed-Cellular Intelligence has acquired Danish drugmaker Novo Nordisk's cell therapy candidate for Parkinson's disease, the biotech firm said on Monday.
NVO DCF Analysis: Intrinsic Value $90 vs Price $46
08:09am, Monday, 11'th May 2026
On May 11, 2026, we delve into the DCF analysis for Novo Nordisk AS (NVO), a company currently facing a challenging price performance landscape. Over the past y
OTC Markets Group announces Evolve Royalties upgrade to OTCQX
05:28am, Monday, 11'th May 2026
OTC Markets Group Inc. (OTCQX:OTCM) announced that Evolve Royalties has qualified to trade on the OTCQX Best Market under the symbol 'EVRYF.' The royalty...
Digi Power X to report Q1 results May 15
05:21am, Monday, 11'th May 2026
Digi Power X Inc (NASDAQ:DGXX, FRA:1NQ0, NEO:DGX) said it will release its first quarter 2026 financial results on May 15 and provide an update on its...
Graphene Manufacturing Group coating technology selected for luxury tower project in Australia
05:07am, Monday, 11'th May 2026
Graphene Manufacturing Group Ltd (TSX-V:GMG, OTCQX:GMGMF) announced that its THERMAL-XR graphene coating solution is being applied to air conditioning units...
Bit Digital names Daniel Kennedy as head of investor relations
04:36am, Monday, 11'th May 2026
Bit Digital Inc (NASDAQ:BTBT) announced Monday it has appointed Daniel Kennedy as its new head of investor relations. Kennedy, a former board member,...
AI, Obesity Drugs, and Diagnostics Fuel Healthcare Growth
02:30pm, Sunday, 10'th May 2026
Healthcare is regaining momentum as innovation—especially AI‑driven drug discovery—creates new growth opportunities, according to Shivani Vohra. She points to obesity treatments from Eli Lilly (
Novo Nordisk: Flipping The Script
11:34am, Sunday, 10'th May 2026
Novo Nordisk is turning the corner with a highly successful launch of its Wegovy weight-loss pill, outpacing competitors. The Wegovy pill achieved over 2 million prescriptions since January, significa
Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?
06:05am, Saturday, 09'th May 2026
The weight loss drug market is on track to reach almost $100 billion.
Oral Ozempic and Wegovy pills now available for same-day delivery on Amazon
03:51am, Saturday, 09'th May 2026
"This has been the best product launch in the last decade that we have seen."
Novo Nordisk India Sales Jump After Price Cuts
01:22pm, Friday, 08'th May 2026
Novo Nordisk (NVO, Financials) recorded a sharp rise in India sales for its semaglutide drugs after cutting prices to defend demand against lower-cost generic c
